메뉴 건너뛰기




Volumn 123, Issue 5, 2009, Pages 715-718

Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis

(15)  Gando, Satoshi a   Saitoh, Daizoh b   Ogura, Hiroshi c   Mayumi, Toshihiko d   Koseki, Kazuhide e   Ikeda, Toshiaki f   Ishikura, Hiroyasu g   Iba, Toshiaki h   Ueyama, Masashi i   Eguchi, Yutaka j   Otomo, Yasuhiro k   Okamoto, Kohji l   Kushimoto, Shigeki m   Endo, Shigeatsu n   Shimazaki, Shuji o  


Author keywords

Criteria; Diagnosis; Disseminated intravascular coagulation (DIC); International Society on Thrombosis and Haemostasis (ISTH); Sepsis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS;

EID: 60449106321     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.07.006     Document Type: Article
Times cited : (66)

References (12)
  • 1
    • 34548214668 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation
    • Levi M. Disseminated intravascular coagulation. Crit Care Med 35 (2007) 2191-2195
    • (2007) Crit Care Med , vol.35 , pp. 2191-2195
    • Levi, M.1
  • 2
    • 0035160476 scopus 로고    scopus 로고
    • Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation
    • Taylor Jr. F.B., Toh C.H., Hoot W.K., Wada H., and Levi M. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
    • (2001) Thromb Haemost , vol.86 , pp. 1327-1330
    • Taylor Jr., F.B.1    Toh, C.H.2    Hoot, W.K.3    Wada, H.4    Levi, M.5
  • 3
    • 0142122040 scopus 로고    scopus 로고
    • Non-overt disseminated intravascular coagulation: definition and pathophysiological implications
    • (suppl)
    • Hoots W.K. Non-overt disseminated intravascular coagulation: definition and pathophysiological implications. Blood Rev 16 (2002) S3-S9 (suppl)
    • (2002) Blood Rev , vol.16
    • Hoots, W.K.1
  • 4
    • 33644589346 scopus 로고    scopus 로고
    • A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria
    • Japanese Association for Acute Medicine disseminated intravascular coagulation (JAAM DIC) study group
    • Gando S., et al., Japanese Association for Acute Medicine disseminated intravascular coagulation (JAAM DIC) study group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria. Crit Care Med 34 (2006) 625-631
    • (2006) Crit Care Med , vol.34 , pp. 625-631
    • Gando, S.1
  • 5
    • 37548998584 scopus 로고    scopus 로고
    • Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey
    • Japanese Association for Acute Medicine disseminated intravascular coagulation (JAAM DIC) study group
    • Gando S., et al., Japanese Association for Acute Medicine disseminated intravascular coagulation (JAAM DIC) study group. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 36 (2008) 145-150
    • (2008) Crit Care Med , vol.36 , pp. 145-150
    • Gando, S.1
  • 7
    • 0031735051 scopus 로고    scopus 로고
    • Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study
    • Vincent J.L., de Mendonça A., Cantraine F., Moreno R., Takala J., Suter P.M., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26 (1998) 1793-1800
    • (1998) Crit Care Med , vol.26 , pp. 1793-1800
    • Vincent, J.L.1    de Mendonça, A.2    Cantraine, F.3    Moreno, R.4    Takala, J.5    Suter, P.M.6
  • 8
    • 0026874127 scopus 로고
    • Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis
    • Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
    • Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee, and American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
    • (1992) Crit Care Med , vol.20 , pp. 864-874
  • 9
    • 0035840891 scopus 로고    scopus 로고
    • Serial evaluation of the SOFA score to predict outcome in critically ill patients
    • Ferreira F.L., Bota D.P., Bross A., Mélot C., and Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286 (2001) 1754-1758
    • (2001) JAMA , vol.286 , pp. 1754-1758
    • Ferreira, F.L.1    Bota, D.P.2    Bross, A.3    Mélot, C.4    Vincent, J.L.5
  • 10
    • 0028893025 scopus 로고
    • The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
    • Range-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., and Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995) 117-123
    • (1995) JAMA , vol.273 , pp. 117-123
    • Range-Frausto, M.S.1    Pittet, D.2    Costigan, M.3    Hwang, T.4    Davis, C.S.5    Wenzel, R.P.6
  • 11
    • 1842547895 scopus 로고    scopus 로고
    • Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation
    • Dhainaut J.F., Yan S.B., Joyce D.E., Pettilä V., Basson B., Sundin D.P., et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2 (2004) 1924-1933
    • (2004) J Thromb Haemost , vol.2 , pp. 1924-1933
    • Dhainaut, J.F.1    Yan, S.B.2    Joyce, D.E.3    Pettilä, V.4    Basson, B.5    Sundin, D.P.6
  • 12
    • 33644859949 scopus 로고    scopus 로고
    • Treatments effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
    • Kienast J., Juers M., Wiedermann C.J., Hoffmann J.N., Ostermann H., Strauss R., et al. Treatments effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4 (2006) 90-97
    • (2006) J Thromb Haemost , vol.4 , pp. 90-97
    • Kienast, J.1    Juers, M.2    Wiedermann, C.J.3    Hoffmann, J.N.4    Ostermann, H.5    Strauss, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.